The Economics of NGS: A Cost Comparison of NGS Implementations with Legacy Technologies

06/06/2016

Authors: Nóra Nagy, Efi Melista, Krisztina Rigó, Peter Meintjes, Tim Hague Abstract: Recent technological advances in sequencing and related library preparation methods, cumulatively called Next Generation Sequencing (NGS) have provided new opportunities that allow the complete characterisation of the HLA genes in haploid fashion and are beginning to make their way...

Omixon Rock the EFI Conference 2016, Kos

26/05/2016

Thank you to all our wonderful customers, co-vendors and distributors for visiting our booth joining our events and just generally hanging out in the sun, by the pool, or in the bar or over coffee at the 30th annual EFI meeting in Kos, Greece during 10-14 May, 2016! Because of all...

Holotype HLA Early Access Program Results: An “Uncontrolled” Study

26/05/2016

Authors: Efi Melista, Krisztina Rigó, Szilveszter Juhos, György Horváth, Peter Meintjes, Tim Hague Abstract: NGS-based (Next Generation Sequencing) HLA typing can offer accurate and unambiguous genotyping results with minimal manual intervention, eliminating the requirement for reflexive testing. In a clinical setting an easy-to-follow protocol with minimal hands-on time is also essential....

Omixon at the EFI Annual Meeting 2016

26/04/2016

Omixon announce today that Holotype HLA™ and other Omixon products will be featured in six poster presentations produced by Holotype customers at the annual meeting of the European Federation for Immunogenetics (EFI) on Kos, in Greece. Additionally, Omixon’s Lunch Symposium on Thursday will focus on the EFI accreditation process for NGS using...

Join Omixon for Our Two Workshops and Lunch Symposium at EFI 2016!

04/04/2016

Lunch Symposium: NGS Accreditation with EFI Standards Omixon’s Lunch Symposium will focus on the EFI accreditation process for NGS using the latest EFI standards and feature three presentations from current Holotype HLA users in Europe. Omixon’s CEO, Tim Hague will announce major product enhancements and new directions for the company. Date: Thursday,...